STARBURST dendrimer-based MRI contrast agents (Dendritic Nanotechnology)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSTARBURST dendrimer-based MRI contrast agents (Dendritic Nanotechnology)
Drug Alias NameMRI imaging agents (Starpharma)
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCardiovascular DiseasesOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDendritic Nanotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDendritic Nanotechnologies Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A